Skip to main content

Articles

Page 3 of 81

  1. The capacity of skeletal muscles to regenerate relies on Pax7+ muscle stem cells (MuSC). While in vitro-amplified MuSC are activated and lose part of their regenerative capacity, in vitro-generated human muscle r...

    Authors: Axelle Bouche, Benoit Borner, Chloé Richard, Ysaline Grand, Didier Hannouche and Thomas Laumonier
    Citation: Stem Cell Research & Therapy 2023 14:243
  2. Melanocytes are an essential part of the epidermis, and their regeneration has received much attention because propagation of human adult melanocytes in vitro is too slow for clinical use. Differentiation from...

    Authors: Chie Kobori, Ryo Takagi, Ryo Yokomizo, Sakie Yoshihara, Mai Mori, Hiroto Takahashi, Palaksha Kanive Javaregowda, Tomohiko Akiyama, Minoru S. H. Ko, Kazuo Kishi and Akihiro Umezawa
    Citation: Stem Cell Research & Therapy 2023 14:242
  3. Mutations in the cardiac sodium channel gene SCN5A cause Brugada syndrome (BrS), an arrhythmic disorder that is a leading cause of sudden death and lacks effective treatment. An association between SCN5A and Wnt/...

    Authors: Dongsheng Cai, Xiaochen Wang, Yaxun Sun, Hangping Fan, Jingjun Zhou, Zongkuai Yang, Hangyuan Qiu, Jue Wang, Jun Su, Tingyu Gong, Chenyang Jiang and Ping Liang
    Citation: Stem Cell Research & Therapy 2023 14:241
  4. Human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) can be used to treat heart diseases; however, the optimal maturity of hiPSC-CMs for effective regenerative medicine remains unclear. We ai...

    Authors: Yuki Tanaka, Shin Kadota, Jian Zhao, Hideki Kobayashi, Satomi Okano, Masaki Izumi, Yusuke Honda, Hajime Ichimura, Naoko Shiba, Takeshi Uemura, Yuko Wada, Shinichiro Chuma, Tsutomu Nakada, Shugo Tohyama, Keiichi Fukuda, Mitsuhiko Yamada…
    Citation: Stem Cell Research & Therapy 2023 14:240
  5. Lipodystrophy-associated metabolic disorders caused by Seipin deficiency lead to not only severe lipodystrophy but also neurological disorders. However, the underlying mechanism of Seipin deficiency-induced ne...

    Authors: Jing Yang, Na Yang, Huifang Zhao, Yan Qiao, Yanqiu Li, Chunfang Wang, Kah-Leong Lim, Chengwu Zhang, Wulin Yang and Li Lu
    Citation: Stem Cell Research & Therapy 2023 14:239
  6. This study aimed to explore a novel subtype classification method based on the stemness characteristics of patients with non-small cell lung cancer (NSCLC).

    Authors: Mingshan Liu, Ruihao Zhou, Wei Zou, Zhuofan Yang, Quanjin Li, Zhiguo Chen, Lei jiang and Jingtao Zhang
    Citation: Stem Cell Research & Therapy 2023 14:238
  7. Refractory epilepsy is also known as drug-resistant epilepsy with limited clinical treatment. Benefitting from its safety and easy availability, olfactory mucosa mesenchymal stem cells (OM-MSCs) are considered...

    Authors: Zheng-Zhao Liu, Yan Huang, Chun-Gu Hong, Xin Wang, Ran Duan, Jian-Yang Liu, Jia-Lin He, Da Duan, Hui Xie and Ming Lu
    Citation: Stem Cell Research & Therapy 2023 14:237
  8. Application of autologous adipose-derived stem cells (ASC) for diabetic chronic wounds has become an emerging treatment option. However, ASCs from diabetic individuals showed impaired cell function and subopti...

    Authors: Chun-Wei Li, Tai-Horng Young, Mu-Hui Wang, Ming-Ying Pei, Tsung-Yu Hsieh, Chia-Lang Hsu and Nai-Chen Cheng
    Citation: Stem Cell Research & Therapy 2023 14:236
  9. Although mesenchymal stem cell (MSC) transplantation provides an alternative strategy for end-stage liver disease (ESLD), further widespread application of MSC therapy is limited owing to low cell engraftment ...

    Authors: Shaoxiong Yu, Saihua Yu, Haiyan Liu, Naishun Liao and Xiaolong Liu
    Citation: Stem Cell Research & Therapy 2023 14:235
  10. Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive, and irreversible lung disease characterized by pulmonary fibrosis and lung dysfunction, ultimately leading to respiratory failure. Many preclinica...

    Authors: Qun Liu, Youkun Bi, Shaole Song, Keqi Zhu, Xinlong Qiao, Huiwen Wang and Guangju Ji
    Citation: Stem Cell Research & Therapy 2023 14:234
  11. To explore whether local transplantation of mesenchymal stem cells (MSCs) in temporal muscle can promote collateral angiogenesis and to analyze its main mechanisms of promoting angiogenesis.

    Authors: Xincheng Zhang, Yimin Huang, Yuan Liu, Yanchao Liu, Xuejun He, Xiaopeng Ma, Chao Gan, Xin Zou, Sheng Wang, Kai Shu, Ting Lei and Huaqiu Zhang
    Citation: Stem Cell Research & Therapy 2023 14:233
  12. Enteric neuropathies, which result from abnormalities of the enteric nervous system, are associated with significant morbidity and high health-care costs, but current treatments are unsatisfactory. Cell-based ...

    Authors: Ryo Hotta, Ahmed Rahman, Sukhada Bhave, Rhian Stavely, Weikang Pan, Shriya Srinivasan, Geoffrey de Couto, Luis Rodriguez-Borlado, Richard Myers, Alan J. Burns and Allan M. Goldstein
    Citation: Stem Cell Research & Therapy 2023 14:232
  13. Stem cells play a therapeutic role mainly through immunoregulation. However, the immunomodulatory function of stem cells may be affected by inflammation-related factors in patients’ serum. Therefore, this stud...

    Authors: Yong-Hong Wang, Meng-Lan Wang, Ya-Chao Tao, Dong-Bo Wu, En-Qiang Chen and Hong Tang
    Citation: Stem Cell Research & Therapy 2023 14:231
  14. Inflammation is the host's protective response against harmful external stimulation that helps tissue repair and remodeling. However, excessive inflammation seriously threatens the patient's life. Due to anti-...

    Authors: Guan-qiao Liu, Zi-xian Liu, Ze-xin Lin, Peng Chen, Yu-chi Yan, Qing-rong Lin, Yan-jun Hu, Nan Jiang and Bin Yu
    Citation: Stem Cell Research & Therapy 2023 14:230
  15. Native bone marrow (BM) mesenchymal stem/stromal cells (BM-MSCs) participate in generating and shaping the skeleton and BM throughout the lifespan. Moreover, BM-MSCs regulate hematopoiesis by contributing to t...

    Authors: Loïc Fiévet, Nicolas Espagnolle, Daniela Gerovska, David Bernard, Charlotte Syrykh, Camille Laurent, Pierre Layrolle, Julien De Lima, Arthur Justo, Nicolas Reina, Louis Casteilla, Marcos J. Araúzo-Bravo, Abderrahim Naji, Jean-Christophe Pagès and Frédéric Deschaseaux
    Citation: Stem Cell Research & Therapy 2023 14:229
  16. In the last decade, human-induced pluripotent stem cell-derived cardiomyocyte (hiPSC-CM)-based cell therapy has drawn broad attention as a potential therapy for treating injured hearts. However, mass productio...

    Authors: Hao Yang, Yuan Yang, Fedir N. Kiskin, Mengcheng Shen and Joe Z. Zhang
    Citation: Stem Cell Research & Therapy 2023 14:228
  17. A resident vascular endothelial stem cell (VESC) population expressing CD157 and CD200 has been identified recently in the adult mouse. However, the origin of this population and how it develops has not been c...

    Authors: Fitriana N. Rahmawati, Tomohiro Iba, Hisamichi Naito, Shota Shimizu, Hirotaka Konishi, Weizhen Jia and Nobuyuki Takakura
    Citation: Stem Cell Research & Therapy 2023 14:227
  18. Articular cartilage (AC)’s main function is to resist to a stressful mechanical environment, and chondrocytes are responding to mechanical stress for the development and homeostasis of this tissue. However, cu...

    Authors: Noémie Petitjean, Patrick Canadas, Christian Jorgensen, Pascale Royer, Simon Le Floc’h and Danièle Noël
    Citation: Stem Cell Research & Therapy 2023 14:226
  19. Antlers are the only fully regenerable mammalian appendages whose annual renewal is initiated by antler stem cells (ASCs), defined as a specialized type of mesenchymal stem cells (MSCs) with embryonic stem cel...

    Authors: Qi Liu, Jiannan Li, Jinghui Chang, Yu Guo and Dacheng Wen
    Citation: Stem Cell Research & Therapy 2023 14:225
  20. Induced pluripotent stem cells (iPSC) can be differentiated to cells in all three germ layers, as well as cells in the extraembryonic tissues. Efforts in iPSC differentiation into pancreatic progenitors in vit...

    Authors: Matthew R. Arkenberg, Yoshitomo Ueda, Eri Hashino and Chien-Chi Lin
    Citation: Stem Cell Research & Therapy 2023 14:223
  21. Mesenchymal stem cells (MSCs) are widely used in cell therapy, tissue engineering, and regenerative medicine because of their self-renewal, pluripotency, and immunomodulatory properties. The microenvironment i...

    Authors: Zhilong Huang, Yingying Huang, Xiner Ning, Haodi Li, Qiqi Li and Junjie Wu
    Citation: Stem Cell Research & Therapy 2023 14:222
  22. Chronic limb-threatening ischemia (CLTI) represents the final stage of peripheral arterial disease. Approximately one-third of patients with CLTI are not eligible for conventional surgical treatments. Furtherm...

    Authors: Martha L. Arango-Rodríguez, Ligia C. Mateus, Claudia L. Sossa, Silvia M. Becerra-Bayona, Víctor Alfonso Solarte-David, Miguel Enrique Ochoa Vera, Lady T. Giratá Viviescas, Ana M. Vera Berrio, Sergio Eduardo Serrano, Oliverio Vargas, Andrés Catalá Isla, Alape Benitez and Germán Rangel
    Citation: Stem Cell Research & Therapy 2023 14:221
  23. Xerostomia is a salivary gland dysfunction that negatively impacts the life quality of patients; however, there is no effective treatment for xerostomia. Bioengineered organs, generated using stem cells obtain...

    Authors: Bo kyoung Kang, Zhu Zhu, Jian Wang, Jia Zhou, Shun Yu, Xianyu Zhou, Zhenmin Zhao, Aiguo Xie, Lin Lu and Jun Yang
    Citation: Stem Cell Research & Therapy 2023 14:220
  24. Androgenetic alopecia (AGA) is one of the most common hair loss diseases worldwide. However, current treatments including medicine, surgery, and stem cells are limited for various reasons. Cell-free fat extrac...

    Authors: Yizuo Cai, Zhuoxuan Jia, Yichen Zhang, Bijun Kang, Chingyu Chen, Wei Liu, Wei Li and Wenjie Zhang
    Citation: Stem Cell Research & Therapy 2023 14:219
  25. Following an ischemic injury to the brain, the induction of angiogenesis is critical to neurological recovery. The angiogenic benefits of mesenchymal stem cells (MSCs) have been attributed at least in part to ...

    Authors: Jolene Phelps, David A. Hart, Alim P. Mitha, Neil A. Duncan and Arindom Sen
    Citation: Stem Cell Research & Therapy 2023 14:218
  26. Acute respiratory distress syndrome (ARDS) is a life-threatening inflammatory lung injury with high mortality; no approved medication exists. Efficacy and safety of bone marrow–derived, allogeneic, multipotent...

    Authors: Kazuya Ichikado, Toru Kotani, Yasuhiro Kondoh, Hideaki Imanaka, Takeshi Johkoh, Kiminori Fujimoto, Shin Nunomiya, Tomotaka Kawayama, Masanori Sawada, Eric Jenkins, Sadatomo Tasaka and Satoru Hashimoto
    Citation: Stem Cell Research & Therapy 2023 14:217
  27. Mesenchymal stem/stromal cells (MSCs) have been used in clinical trials for various diseases. These have certain notable functions such as homing to inflammation sites, tissue repair, and immune regulation. In...

    Authors: Yukiya Takayama, Kosuke Kusamori, Yuri Katsurada, Shu Obana, Shoko Itakura and Makiya Nishikawa
    Citation: Stem Cell Research & Therapy 2023 14:216
  28. Redox signaling and energy metabolism are known to be involved in controlling the balance between self-renewal and proliferation/differentiation of stem cells. In this study we investigated metabolic and redox...

    Authors: Francesca Agriesti, Francesca Landini, Mirko Tamma, Consiglia Pacelli, Carmela Mazzoccoli, Giovanni Calice, Vitalba Ruggieri, Giuseppe Capitanio, Giorgio Mori, Claudia Piccoli and Nazzareno Capitanio
    Citation: Stem Cell Research & Therapy 2023 14:215
  29. The apolipoprotein E (APOE) gene is the strongest genetic risk factor for Alzheimer’s disease (AD); however, how it modulates brain homeostasis is not clear. The apoE protein is a major lipid carrier in the brain...

    Authors: Jing Zhao, Tadafumi C. Ikezu, Wenyan Lu, Jesse R. Macyczko, Yonghe Li, Laura J. Lewis-Tuffin, Yuka A. Martens, Yingxue Ren, Yiyang Zhu, Yan W. Asmann, Nilüfer Ertekin-Taner, Takahisa Kanekiyo and Guojun Bu
    Citation: Stem Cell Research & Therapy 2023 14:214
  30. Senescent adipose-derived stem cells (ASCs) exhibit reduced therapeutic efficacy during wound healing. Transcriptional regulation factors including long noncoding RNAs (lncRNAs) reportedly have essential roles...

    Authors: Hewei Xiong, Sen Ren, Jing Chen, Xiaofan Yang, Yutian Liu, Zhao Xu, Jiahe Guo, Tao Jiang, Meng Yuan, Yang Liu, Guolei Zhang, Wenqing Li, Hans-Günther Machens and Zhenbing Chen
    Citation: Stem Cell Research & Therapy 2023 14:213
  31. Retinitis pigmentosa (RP) is an inherited retinal disease that results in photoreceptor degeneration, leading to severe vision loss or blindness. Due to its genetic heterogeneity, developing a new gene therapy...

    Authors: Eric D. Jong, Sabiha Hacibekiroglu, Lily Guo, Evan Sawula, Biao Li, Chengjin Li, Margaret T. Ho, Molly S. Shoichet, Valerie A. Wallace and Andras Nagy
    Citation: Stem Cell Research & Therapy 2023 14:212
  32. The efficacy of human umbilical cord mesenchymal stem cell (hUC-MSC) transplantation in treating systemic lupus erythematosus (SLE) has been confirmed by small-scale clinical trials. However, these trials focu...

    Authors: Fengbiao Guo, Quanren Pan, Ting Chen, Shuzhen Liao, Shangmei Li, Aifen Li, Shuxian Chen, Jiaxuan Chen, Zengzhi Xiao, Hongyong Su, Lawei Yang, Chen Yang, Hua-feng Liu and Qingjun Pan
    Citation: Stem Cell Research & Therapy 2023 14:211
  33. Treatments for AGA have yet to produce satisfactory outcomes and may cause intolerable side effects. Recent studies have reported that adipose tissue-derived stem cell conditioned media (ADSC-CM) could induce ...

    Authors: Lili Legiawati, Lis Surachmiati Suseno, Irma Bernadette S. Sitohang, Shannaz Nadia Yusharyahya, Jeanne Adiwinata Pawitan, Isabella Kurnia Liem, Trie Kurniawati, Athaya Ardelia and Kanya Paramastri
    Citation: Stem Cell Research & Therapy 2023 14:210
  34. Recent advances in methods to culture pluripotent stem cells to model human development have resulted in entities that increasingly have recapitulated advanced stages of early embryo development. These entitie...

    Authors: Ana S. Iltis, Grace Koster, Emily Reeves and Kirstin R. W. Matthews
    Citation: Stem Cell Research & Therapy 2023 14:209
  35. Stem cell therapy is the most promising treatment option for regenerative medicine. Therapeutic effect of different stem cells has been verified in various disease model. Dedifferentiated fat (DFAT) cells, der...

    Authors: Zhuokai Liang, Yufei He, Haojing Tang, Jian Li, Junrong Cai and Yunjun Liao
    Citation: Stem Cell Research & Therapy 2023 14:207
  36. Immunomodulation by mesenchymal stromal cells (MSCs) can occur through trophic factor mechanisms, however, intravenously infused MSCs are rapidly cleared from the body yet a potent immunotherapeutic response i...

    Authors: Michael V. Schrodt, Riley M. Behan-Bush, Jesse N. Liszewski, Madeleine E. Humpal-Pash, Lauren K. Boland, Sabrina M. Scroggins, Donna A. Santillan and James A. Ankrum
    Citation: Stem Cell Research & Therapy 2023 14:206
  37. Skeletal muscle comprises almost 40% of the human body and is essential for movement, structural support and metabolic homeostasis. Size of multinuclear skeletal muscle is stably maintained under steady condit...

    Authors: Takamitsu Tatsukawa, Kohei Kano, Kei-ichi Nakajima, Takashi Yazawa, Ryoji Eguchi, Maki Kabara, Kiwamu Horiuchi, Taiki Hayasaka, Risa Matsuo, Naoyuki Hasebe, Nobuyoshi Azuma and Jun-ichi Kawabe
    Citation: Stem Cell Research & Therapy 2023 14:205
  38. Skeletal muscle regeneration is a complex process regulated by many cytokines and growth factors. Among the important signaling pathways regulating the myogenic cell identity are these involving SDF-1 and NOTC...

    Authors: Bartosz Mierzejewski, Iwona Grabowska, Zuzanna Michalska, Kamila Zdunczyk, Franciszek Zareba, Aliksandra Irhashava, Marta Chrzaszcz, Magdalena Patrycy, Wladyslawa Streminska, Katarzyna Janczyk-Ilach, Marta Koblowska, Roksana Iwanicka-Nowicka, Agnieszka Gromadka, Kamil Kowalski, Maria Anna Ciemerych and Edyta Brzoska
    Citation: Stem Cell Research & Therapy 2023 14:204
  39. Orofacial soft tissue wounds caused by surgery for congenital defects, trauma, or disease frequently occur leading to complications affecting patients' quality of life. Scarring and fibrosis prevent proper ski...

    Authors: Zhihao Wang, Rob Knight, Phil Stephens, E. M. Ongkosuwito, Frank A. D. T. G. Wagener and Johannes W. Von den Hoff
    Citation: Stem Cell Research & Therapy 2023 14:203
  40. Mitochondrial dysfunction is involved in several diseases ranging from genetic mitochondrial disorders to chronic metabolic diseases. An emerging approach to potentially treat mitochondrial dysfunction is the ...

    Authors: David F. Bodenstein, Pavel Powlowski, Kassandra A. Zachos, Dana El Soufi El Sabbagh, Hyunjin Jeong, Liliana Attisano, Landon Edgar, Douglas C. Wallace and Ana Cristina Andreazza
    Citation: Stem Cell Research & Therapy 2023 14:202
  41. Human multilineage-differentiating stress enduring (Muse) cells are nontumorigenic endogenous pluripotent-like stem cells that can be easily obtained from various adult or fetal tissues. Regenerative effects o...

    Authors: Honorine Dushime, Stéphanie G. Moreno, Christine Linard, Annie Adrait, Yohann Couté, Juliette Peltzer, Sébastien Messiaen, Claire Torres, Lydia Bensemmane, Daniel Lewandowski, Paul-Henri Romeo, Vanessa Petit and Nathalie Gault
    Citation: Stem Cell Research & Therapy 2023 14:201
  42. Advanced renal cell carcinoma (RCC) is therapeutically challenging. RCC progression is facilitated by mesenchymal stem/stromal cells (MSCs) that exert remarkable tumor tropism. The specific mechanisms mediatin...

    Authors: Piotr Popławski, Weronika Zarychta-Wiśniewska, Anna Burdzińska, Joanna Bogusławska, Anna Adamiok-Ostrowska, Karolina Hanusek, Beata Rybicka, Alex Białas, Helena Kossowska, Roksana Iwanicka-Rokicka, Marta Koblowska, Leszek Pączek and Agnieszka Piekiełko-Witkowska
    Citation: Stem Cell Research & Therapy 2023 14:200
  43. Induced pluripotent stem cells (iPS) can be generated from various somatic cells and can subsequently be differentiated to multiple cell types of the body. This makes them highly promising for cellular therapy...

    Authors: Hassan R. W. Ali, Salwa Suliman, Tarig Al-Hadi Osman, Manuel Carrasco, Ove Bruland, Daniela-Elena Costea, Helge Ræder and Kamal Mustafa
    Citation: Stem Cell Research & Therapy 2023 14:199
  44. Regenerative repair of the brain after traumatic brain injury (TBI) remains an extensive clinical challenge, inspiring intensified interest in therapeutic approaches to explore superior repair strategies. Exos...

    Authors: Lin Zhong, Jingjing Wang, Peng Wang, Xiaoyin Liu, Peng Liu, Xu Cheng, Lujia Cao, Hongwei Wu, Jing Chen and Liangxue Zhou
    Citation: Stem Cell Research & Therapy 2023 14:198
  45. Mesenchymal stem cell (MSC) treatment plays a major role in the management of acute lung injury (ALI), and neutrophils are the initial line of defense against ALI. However, the effect of MSCs on neutrophils in...

    Authors: Bing Feng, Xudong Feng, Yingduo Yu, Haoying Xu, Qingqing Ye, Ruitian Hu, Xinru Fang, Feiqiong Gao, Jian Wu, Qiaoling Pan, Jiong Yu, Guanjing Lang, Lanjuan Li and Hongcui Cao
    Citation: Stem Cell Research & Therapy 2023 14:197
  46. High dosage of dexamethasone (Dex) is an effective treatment for multiple diseases; however, it is often associated with severe side effects including muscle atrophy, resulting in higher risk of falls and poor...

    Authors: Belle Yu-Hsuan Wang, Allen Wei-Ting Hsiao, Hoi Ting Shiu, Nicodemus Wong, Amanda Yu-Fan Wang, Chien-Wei Lee, Oscar Kuang-Sheng Lee and Wayne Yuk-Wai Lee
    Citation: Stem Cell Research & Therapy 2023 14:195
  47. Many problems related to disorders and defects of bone tissue caused by aging, diseases, and injuries have been solved by the multidisciplinary research field of regenerative medicine and tissue engineering. N...

    Authors: Hadi Sadeghzadeh, Hassan Dianat-Moghadam, Azizeh Rahmani Del Bakhshayesh, Daryush Mohammadnejad and Ahmad Mehdipour
    Citation: Stem Cell Research & Therapy 2023 14:194

Annual Journal Metrics

  • 2022 Citation Impact
    7.5 - 2-year Impact Factor
    8.0 - 5-year Impact Factor
    1.440 - SNIP (Source Normalized Impact per Paper)
    1.498 - SJR (SCImago Journal Rank)

    2022 Speed
    8 days submission to first editorial decision for all manuscripts (Median)
    112 days submission to accept (Median)

    2022 Usage 
    3,475,685 downloads
    3,199 Altmetric mentions